{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/103320693"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Overall, however, our critique of the federal DPA process does not hinge on a belief that it treats corporations too harshly???though, in particular instances, such as off-label drug promotion, that is almost certainly the case." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "manhattan-institute.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/84089316"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/103320693"] } } }
